Evaxion A (EVAX) Net Cash Flow (2020 - 2022)
Evaxion A (EVAX) reported Net Cash Flow of -$5.6 million for Q2 2022, down 143.25% on a YoY basis from $12.9 million in Q2 2021, and down 817.13% quarter-over-quarter from -$607000.0 in Q1 2022.
Evaxion A (EVAX) Net Cash Flow (2020 - 2022) Analysis & Trends
Evaxion A has reported Net Cash Flow for 3 years, with the latest figure at -$5.6 million in Q2 2022.
- For the quarter ending Q2 2022, Net Cash Flow fell 143.25% year-over-year to -$5.6 million; the trailing twelve-month figure through Mar 2023 stood at -$5.6 million (down 130.18% YoY), and the FY2025 full-year result was $15.8 million, up 131525.0% from the prior year.
- Net Cash Flow for Q2 2022 stood at -$5.6 million, down from -$607000.0 in the prior quarter.
- The five-year high for Net Cash Flow was $20.9 million in Q1 2021, with the low at -$5.6 million in Q2 2022.
- Historically, Net Cash Flow has averaged $2.9 million across 3 years, with a median of -$1.2 million in 2020.
- Annual changes were most pronounced in 2021 — Net Cash Flow jumped 785.14% — and 2022, when it slumped 143.25%.
- Evaxion A's Net Cash Flow stood at -$1.7 million in 2020, then jumped by 462.31% to $6.2 million in 2021, then slumped by 190.07% to -$5.6 million in 2022.
- The last three Net Cash Flow figures came in at -$5.6 million (Q2 2022), -$607000.0 (Q1 2022), and $6.2 million (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | -152.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -5.57 Mn |
| Jun 30, 2022 | -5.57 Mn |
| Mar 31, 2022 | -607,000.00 |
| Mar 31, 2022 | -607,000.00 |
| Sep 30, 2021 | 6.18 Mn |
| Sep 30, 2021 | 6.18 Mn |
| Jun 30, 2021 | 12.87 Mn |
| Jun 30, 2021 | 12.87 Mn |
| Mar 31, 2021 | 20.89 Mn |
| Mar 31, 2021 | 20.89 Mn |
| Sep 30, 2020 | -1.71 Mn |
| Sep 30, 2020 | -1.71 Mn |
| Jun 30, 2020 | -5.42 Mn |
| Jun 30, 2020 | -5.42 Mn |
| Mar 31, 2020 | -3.05 Mn |
| Mar 31, 2020 | -3.05 Mn |